admin Share This! FacebookTwitterPinterestLinkedIn Investing News Pfizer Q2 Revenue Misses Expectations as COVID Product Demand Slumps August 1, 202368 Views1 Min Read Drugmaker Pfizer’s Q2 earnings showed mixed results. EPS beat analyst expectations but revenue declined on falling demand for its COVID products. You may also like Investing News Popular Careers in the Financial Sector 14 hours ago Investing News Budgeting When You’re Broke 14 hours ago Investing News Continuous Compound Interest: How It Works With Examples 17 hours ago Merck Beats Quarterly Estimates, Lifts Outlook on Sales of Cancer Drug, HPV Shot BP Is Latest Energy Firm to Report Profit Drop on Lower Oil and Gas Prices Share This! FacebookTwitterPinterestLinkedIn Newsletter NavigationInvesting News Market Insider Stock Market Stocks to buy Stocks to sell Dividend Stocks Trader Talk Videos Privacy Policy DMCA / Copyrights Disclaimer Terms and Conditions Disclaimer Whitelist Us